Mon, November 7, 2022
Fri, November 4, 2022
Thu, November 3, 2022

Tiago Fauth Maintained (BCAB) at Hold with Increased Target to $8 on, Nov 4th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -with-increased-target-to-8-on-nov-4th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Tiago Fauth of Credit Suisse, Maintained "BioAtla, Inc." (BCAB) at Hold with Increased Target from $4 to $8 on, Nov 4th, 2022.

Tiago has made no other calls on BCAB in the last 4 months.



There are 2 other peers that have a rating on BCAB. Out of the 2 peers that are also analyzing BCAB, 0 agree with Tiago's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Tiago


  • Reni Benjamin of "JMP Securities" Initiated at Buy and Held Target at $17 on, Thursday, September 15th, 2022
  • Swayampakula Ramakanth of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $20 on, Wednesday, August 10th, 2022

Publication Contributing Sources